EAM Investors’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-17,938
Closed -$422K 327
2024
Q2
$422K Hold
17,938
0.07% 238
2024
Q1
$680K Buy
+17,938
New +$680K 0.11% 215
2018
Q3
Sell
-2,269
Closed -$600K 366
2018
Q2
$600K Hold
2,269
0.09% 273
2018
Q1
$563K Buy
+2,269
New +$563K 0.09% 265